1. Home
  2. LUNG vs PELI Comparison

LUNG vs PELI Comparison

Compare LUNG & PELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • PELI
  • Stock Information
  • Founded
  • LUNG 1995
  • PELI 2024
  • Country
  • LUNG United States
  • PELI United States
  • Employees
  • LUNG N/A
  • PELI N/A
  • Industry
  • LUNG Industrial Specialties
  • PELI
  • Sector
  • LUNG Health Care
  • PELI
  • Exchange
  • LUNG Nasdaq
  • PELI NYSE
  • Market Cap
  • LUNG 124.0M
  • PELI 120.1M
  • IPO Year
  • LUNG 2020
  • PELI 2025
  • Fundamental
  • Price
  • LUNG $2.78
  • PELI $10.01
  • Analyst Decision
  • LUNG Buy
  • PELI
  • Analyst Count
  • LUNG 6
  • PELI 0
  • Target Price
  • LUNG $11.53
  • PELI N/A
  • AVG Volume (30 Days)
  • LUNG 311.3K
  • PELI 56.8K
  • Earning Date
  • LUNG 07-30-2025
  • PELI 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • PELI N/A
  • EPS Growth
  • LUNG N/A
  • PELI N/A
  • EPS
  • LUNG N/A
  • PELI N/A
  • Revenue
  • LUNG $87,473,000.00
  • PELI N/A
  • Revenue This Year
  • LUNG $18.02
  • PELI N/A
  • Revenue Next Year
  • LUNG $18.17
  • PELI N/A
  • P/E Ratio
  • LUNG N/A
  • PELI N/A
  • Revenue Growth
  • LUNG 19.84
  • PELI N/A
  • 52 Week Low
  • LUNG $2.50
  • PELI $10.01
  • 52 Week High
  • LUNG $9.37
  • PELI $10.43
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.83
  • PELI N/A
  • Support Level
  • LUNG $2.52
  • PELI N/A
  • Resistance Level
  • LUNG $2.84
  • PELI N/A
  • Average True Range (ATR)
  • LUNG 0.16
  • PELI 0.00
  • MACD
  • LUNG 0.04
  • PELI 0.00
  • Stochastic Oscillator
  • LUNG 46.36
  • PELI 0.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About PELI PELICAN ACQUISITION CORPORATION

Pelican Acquisition Corp is a blank check company.

Share on Social Networks: